newsfilter
← Earnings
Earnings Releases·

Bruker — Third Quarter 2026 Earnings Summary

  • Q3 2026 revenue rose 1.6% YoY to $874.0 million (organic +0.7%), while non-GAAP diluted EPS increased 24.4% to $0.56 and non-GAAP operating margin expanded to 16.3% from 12.3%; GAAP results included a $174.5 million non-cash goodwill impairment charge.
  • Management reconfirmed full-year 2026 revenue guidance of $3.52–$3.56 billion and non-GAAP EPS guidance of $2.10–$2.15, though foreign currency translation is now expected to be neutral rather than a 0.5% tailwind.
  • Future outlook highlights anticipated revenue growth acceleration and double-digit EPS growth in FY2027, supported by strengthening demand in US academic markets and positive booking trends in the BSI segment.
  • Segment performance showed BEST revenue up 11.2% YoY, while BSI revenue grew 0.8% YoY with a book-to-bill ratio exceeding one for five consecutive quarters; cash flow improved significantly with Q3 non-GAAP free cash flow at $96.7 million versus $(54.1) million in the prior year.
Company
BRUKER CORP
Sector
Healthcare
Industry
Medical Devices